Understanding the developmental mechanisms of follicular helper T cells (T FH cells) in humans is relevant to the clinic. However, the factors that drive the differentiation of human CD4 + helper T cells into T FH cells remain largely undefined. Here we found that transforming growth factor-b (TGF-b) provided critical additional signals for the transcription factors STAT3 and STAT4 to promote initial T FH differentiation in humans. This mechanism did not appear to be shared by mouse helper T cells. Developing human T FH cells that expressed the transcriptional repressor Bcl-6 also expressed RORgt, a transcription factor typically expressed by the T H 17 subset of helper T cells. Our study documents a mechanism by which T FH cells and T H 17 cells emerge together in inflammatory environments in humans, as is often observed in many human autoimmune diseases.
Follicular helper T cells (T FH cells) serve a major role in the generation
of antigen-specific antibody responses by providing help to B cells 1 . T FH cells are essential for the formation of germinal centers (GCs), where high-affinity B cells are selected and differentiate into longlived memory B cells and plasma cells 2 . The chemokine receptor CXCR5 is expressed by T FH cells and guides their migration toward B cell follicles 1 . T FH cells have high expression of the inducible costimulatory molecule ICOS, which is critical for their development 3, 4 , migration into follicles 5 and function 6 . T FH cells support the survival of GC B cells and their differentiation into memory cells and plasma cells through secretion of interleukin 21 (IL-21) 7 and by providing signals through CD40, a member of the tumor-necrosis factor receptor superfamily 1 . While T FH cells are important for antibody responses to infectious agents, exaggerated T FH cell responses cause autoimmunity 8 . Therefore, defining the developmental mechanisms of T FH cells in humans is a topic highly relevant to human pathophysiology and would provide direct insights into the design of new vaccines for infectious diseases and the development of novel therapeutic approaches for autoimmune diseases.
The precursors of T FH cells interact with B cells at the border of the T cell zone and follicles. Prolonged and stable interactions with B cells are essential for the maturation of those precursors into GC T FH cells 1, 9 . Nonetheless, dendritic cells (DCs) are important in the early stage of the generation of T FH cells. Programming for the differentiation of CD4 + helper T cells into T FH cell occurs as early as the first few divisions following interaction with DCs 4, 9, 10 . DC-derived cytokines that activate the transcription factors STAT3 (ref. 11 ) and STAT4 (ref. 12) induce the interacting helper T cells to express Bcl-6, a transcriptional repressor essential for the maturation of T FH cells [13] [14] [15] . The function of Bcl-6 is inhibited by the transcriptional repressor Blimp-1 and, accordingly, Blimp-1 inhibits the generation of T FH cells 13 . ICOS ligand expressed by DCs also contributes to the expression of Bcl-6 in helper T cells 4 . Therefore, encounters with DCs largely predetermine whether helper T cells differentiate into the T FH cell lineage 9 .
As with other helper T cell subsets, cytokine signals are important for the early development of T FH cells. Published studies have suggested differences between humans and mice in the dominant cytokines involved in T FH cell development. In mice, IL-6, IL-21 and IL-27 (which activate STAT3) have dominant roles 1, 16 , while IL-12 (which activates mainly STAT4) can also participate in the early phase 12 . In contrast, IL-12 appears to be more important than IL-6, IL-21 or IL-27 for the generation of T FH cells in humans 17, 18 . IL-12 induces higher expression of IL-21, ICOS, CXCR5 and Bcl-6 on activated human naive helper T cells than do IL-6, IL-21 or IL- 27 (refs. 18,19) . However, IL-12 is also linked to the generation of the T H 1 subset of helper T cells, which suggests that additional factors may also contribute to the generation of human T FH cells. How signaling via STAT4 and STAT3 contributes to the generation of human T FH cells also remains to be established.
Here we found that TGF-β was an important cofactor for the early differentiation of human T FH cells. TGF-β acted together with IL-12 and IL-23 to induce the expression of various T FH cell molecules by human naive helper T cells, including CXCR5, ICOS, IL-21, Bcl-6 and the transcription factors BATF and c-Maf, and to downregulate the expression of Blimp-1. We did not find this stimulatory effect of TGF-β on the development of T FH cells in mice. In humans, in the presence of TGF-β, STAT4 and STAT3 contributed to the differentiation of naive helper T cells into the T FH cell lineage in a largely redundant manner and acted together to induce the expression of T FH cell molecules. Furthermore, we found that in humans, cells of the T H 17 subset of helper T cells generated in vitro with the cytokine combination of IL-23, IL-6, IL-1β and TGF-β largely shared properties with T FH cells, which suggested that in humans, the early developmental path of T FH cells and T H 17 cells is shared. We also found T FH cells coexpressing Bcl-6 and the transcription factor RORγt in human tonsils, which provided supportive evidence of the development of T FH cells and T H 17 cells together in inflammatory environments in humans.
RESULTS

TGF-b plus IL-12 and TGF-b plus IL-23 promote CXCR5 expression
We took a systematic approach to determine the cytokine signals that promoted the initial T FH cell-differentiation programs in humans. We obtained naive helper T cells from the blood of 13 different adult human donors, then cultured the cells for 2-4 d with monoclonal antibody to the invariant signaling protein CD3 (anti-CD3) and monoclonal antibody to the coreceptor CD28 (anti-CD28) in the presence of various combinations of cytokines and analyzed the expression of several molecules expressed by T FH cells, including CXCR5, Bcl-6, ICOS and IL-21. For this analysis, we selected cytokines known to regulate T cell differentiation, many of which are secreted by DCs: IL-1β, IL-6, IL-10, IL-12, IL-21, IL-23, type I interferons (IFN-α, IFN-β and IFN-ω), type III interferons (IFN-λ1 and IFN-λ2) and TGF-β. To circumvent the direct inhibitory effect of TGF-β and interferons on the cell cycle, we primed naive helper T cells overnight with anti-CD3 and anti-CD28 before adding cytokines to the cultures. This procedure yielded comparable cell recovery and viability across different cytokine conditions ( Supplementary Fig. 1a ). We ranked the data obtained from naive helper T cells cultured with various cytokines and determined the cytokine conditions that increased the expression of each T FH cell molecule. Of note, we excluded IL-4, a major driver of T H 2 differentiation, from the analysis because published studies suggest that IL-4 by itself does not induce human naive helper T cells to express T FH cell molecules 18, 19 . We further found that IL-4 strongly inhibited the expression of ICOS and IL-21 in naive helper T cells stimulated with IL-12 ( Supplementary Fig. 1b,c) and thus IL-4 might negatively regulate the generation of human T FH cells.
Analysis of the expression of CXCR5 by activated human naive helper T cells (with high forward scatter and side scatter (FSC hi SSC hi )) cultured for 3 d with various cytokines showed that the highest expression of CXCR5 was induced by the cytokine combination of TGF-β plus IL-23 ( Fig. 1a,b and Supplementary Fig. 1d ). Stimulation with TGF-β plus IL-23 or with TGF-β plus IL-12 (also together with IL-1β, IL-6, IL-10 and IL-21) induced higher expression of CXCR5 than did stimulation with IL-23 or IL-12 alone. The cytokine conditions that included either TGF-β plus IL-23 or TGF-β plus IL-12 also promoted the expression of ICOS and IL-21 ( Fig. 1a-c) . In contrast, type I and III interferons yielded low expression of CXCR5 and ICOS and few IL-21 + T cells ( Fig. 1a-c) . Helper T cells cultured with TGF-β plus IL-12 or with TGF-β plus IL-23 efficiently induced B cells to produce immunoglobulin G (IgG) in vitro, while helper T cells cultured with TGF-β alone or with TGF-β plus IL-6 did not ( Fig. 1d) . Thus, the combination of either TGF-β plus IL-12 or TGF-β plus IL-23 promoted the expression of T FH cell markers and induced the ability to efficiently help B cells.
TGF-b plus IL-12 and TGF-b plus IL-23 promote Bcl-6 expression
To assess the early helper T cell differentiation programs at the transcriptional level, we analyzed the expression of transcripts encoding transcription factors with the NanoString nCounter Analysis System, which allows direct measurement of the abundance of transcripts. Similar to results obtained for mouse T FH cells 1, 16 , we confirmed that ex vivo human tonsillar GC T FH cells and their precursors 7 had high expression of BCL6, BATF and MAF but low expression of PRDM1 (which encodes Blimp-1; Supplementary Fig. 2a,b) . We assessed the expression of genes encoding these transcription factors in naive helper T cells obtained from the blood of human adults and cultured for 3 d with various cytokines as described above. We normalized the data obtained to the values obtained for the control culture (without cytokines) in each experiment and used these data to rank the cytokine conditions in order of their induction of gene expression. Either TGF-β plus IL-12 or TGF-β plus IL-23 induced higher BCL6 expression than did IL-12 or IL-23 alone ( Fig. 2a) . Furthermore, the addition of IL-1β and IL-6 to TGF-β plus IL-12 or to TGF-β plus IL-23 further increased BCL6 expression ( Fig. 2a) . Either TGF-β plus IL-12 or TGF-β plus IL-23 also suppressed the expression of PRDM1 ( Fig. 2a) . IL-1β and IL-6 further decreased PRDM1 expression when added to the combination of TGF-β plus IL-12 ( Fig. 2a) . Immunoblot analysis showed that protein expression correlated with the transcript data ( Fig. 2b) . Furthermore, the overall abundance of PRDM1 transcripts negatively correlated with the abundance of BCL6 transcripts ( Fig. 2c ) and, accordingly, the combination of TGF-β, IL-12, IL-1β and IL-6 yielded the highest ratio of BCL6 transcripts to PRDM1 transcripts ( Supplementary Fig. 2c ). We obtained largely similar results with human cord blood-derived naive helper T cells ( Supplementary Fig. 2d ).
The stimulation of human naive helper T cells with the combination of TGF-β plus IL-12 or of TGF-β plus IL-23, together with IL-1β and IL-6, also resulted in high expression of BATF and MAF (Supplementary Figs. 2d and 3a) . In particular, the abundance of BCL6 transcripts showed a strong positive correlation with the abundance of BATF transcripts (R = 0.90 for naive helper T cells from the blood of adult humans and R = 0.84 for naive T H cells from cord blood; Fig. 2c and Supplementary Figs. 2d and 3a) . Kinetics analysis showed that the cytokine combination of TGF-β, IL-12, IL-1β and IL-6 or of TGF-β, IL-23, IL-1β and IL-6, as well as that of TGF-β, IL-12 and IL-23, increased the expression of BCL6 and BATF within 24 h ( Fig. 2d) . While BATF expression peaked at 24 h after cytokine stimulation, BCL6 expression peaked at 72-96 h ( Fig. 2d) , which suggested that BATF directly induced Bcl-6 expression in human helper T cells, as shown in mice 20, 21 . Chromatin-immunoprecipitation experiments indicated that BATF bound to promoter regions of human BCL6 ( Fig. 2e and Supplementary Fig. 3c ). Furthermore, the combination of TGF-β plus IL-12 or of TGF-β plus IL-23 together with IL-1β and IL-6 enhanced the expression of JUN and JUNB ( Supplementary  Fig. 2d ), which encode two transcription factors that form functional heterodimers with BATF 22 . The abundance of JUN and JUNB transcripts also showed strong positive correlation with the abundance of BCL6 transcripts (R = 0.91 and 0.88, respectively; Fig. 2f ). These results suggested that either TGF-β plus IL-12 or TGF-β plus IL-23, together with IL-1β and IL-6, promoted Bcl-6 expression at least in part by upregulating the expression of both components of BATF-Jun heterodimers.
To address whether TGF-β also promotes the expression of T FH cell markers in naive helper T cells primed under physiological conditions, we obtained naive helper T cells from the blood of human adults and stimulated the cells with allogeneic monocyte-derived DCs (activated either by heat-killed Escherichia coli or stimulation with the ligand of CD40) in the presence of 'titrated' amounts of TGF-β. The expression of CXCR5, IL-21 and Bcl-6 was enhanced by a supplementation with 0.2-1 ng/ml of TGF-β ( Supplementary Fig. 3d,e) , consistent with the results obtained with helper T cells stimulated with anti-CD3 and anti-CD28. Collectively, either TGF-β plus IL-12 
Helper T cells near GCs receive TGF-b signaling
The results presented above suggested that when naive helper T cells interacted at T cell zone with activated DCs that produce inflammatory cytokines, including IL-12 and IL-23 (ref. 7) , TGF-β promoted the differentiation of helper T cells toward the T FH cell lineage. Helper T cells in the proximity of tonsillar GCs are known to contain phosphorylated STAT4, which suggests that helper T cells receive signals from IL-12 at these sites 17 . We determined whether TGF-β was also expressed in the T cell zone of inflammatory tonsils from pediatric subjects. We observed abundant expression of TGF-β in the T cell zone near GCs, in particular in the proximity of CD31 + lymphatic and vascular endothelial cells ( Fig. 3a) . More than 50% of the CD11c + DCs located in the T cell zone were positive for TGF-β staining, which indicated that the helper T cells had access to environmental TGF-β and/or TGF-β expressed by DCs. TGF-β mediates its biological functions by binding to type I and type II receptors for TGF-β, which phosphorylate the transcription factors Smad2 and Smad3. Activated Smad molecules translocate into the nucleus 23 . To determine whether helper T cells receive signals from TGF-β in the T cell zone, we analyzed phosphorylated Smad2 in human pediatric tonsils. We found phosphorylated Smad2 in many cells in the inflamed tonsils, including endothelial cells (Fig. 3b) , consistent with abundant expression of TGF-β. Helper T cells in the proximity of GCs (identified by staining with the DNA-binding dye DAPI; data not shown) had phosphorylated Smad2 (Fig. 3b) , and phosphorylated STAT4 (Fig. 3c) in the nucleus. These observations indicated that the T cell zone in inflamed tonsils was enriched for B c l-6 
Coinduction of T FH and T H 17 transcriptional signatures
The observation that the cytokine combination of IL-23, IL-1β, IL-6 and TGF-β, which is commonly used for the generation of human T H 17 cells in vitro 24 , was one of the most efficient combinations tested at inducing BCL6 expression in naive helper T cells (derived from either adult peripheral blood or cord blood samples) suggested that the initial differentiation process of human T H 17 cells might be shared with that of T FH cells. In this context, the global abundance of BCL6 transcripts in cultured naive helper T cells obtained from the blood of adult humans positively correlated with the abundance of transcripts of AHR, RORA and RORC (which encodes RORγt), which encode T H 17 cell-associated transcription factors (Fig. 4a) .
In contrast, the abundance of BCL6 transcripts negatively correlated with the abundance of transcripts of GATA3, FOXP3 and IKZF4 (which encodes Eos) ( Fig. 4a) . We obtained largely similar results in experiments with naive helper T cells from cord blood, except that TBX21 (which encodes T-bet) did not show any correlation with BCL6 (Supplementary Fig. 4) .
Thus, the conditions that promoted T FH differentiation also increased the expression of transcription factors associated with T H 17 cells but decreased the expression of transcription factors associated with T H 2 cells or regulatory T cells (T reg cells).
Unsupervised clustering of the culture conditions according to the transcription factors expressed by naive helper T cells obtained from adult subjects and cultured for 3 d with various cytokines (Fig. 2a ) revealed four clusters (I-IV; Fig. 4b ). The pattern of transcription factor expression in clusters III and IV was largely similar and represented a T FH cell transcriptional signature (such as upregulation of BCL6, BATF and MAF and downregulation of PRDM1). Clusters III and IV also represented a T H 17 cell transcriptional signature (characterized by upregulation of AHR, RORA and RORC and substantially diminished GATA3 expression). The culture conditions that induced the transcriptional signatures characteristic of clusters III and IV included either TGF-β plus IL-12 or TGF-β plus IL-23, with or without IL-1β and/or IL-6. A T reg cell transcriptional signature (upregulation of FOXP3 and IKZF4) was dominant in cluster I and was present in conditions including TGF-β alone and combinations of TGF-β with each of the following: interferons, IL-1β, IL-6, IL-10 and IL-21. This signature was absent in clusters III and IV. Cluster II did not show strong transcriptional signatures of T FH cells, T H 17 cells or T reg cells and was characteristic of stimulatory conditions that lacked TGF-β.
These results suggested that the culture conditions that promoted T FH cell transcriptional signatures also promoted T H 17 cell transcriptional signatures but not T H 2 cell or T reg cell transcriptional signatures.
Developing Bcl-6 + T FH cells coexpress RORgt
We next determined whether the developing T FH cells shared properties with T H 17 cells or whether these two subsets emerge separately. We obtained naive helper T cells from the blood of adult humans, stimulated the cells with anti-CD3 and anti-CD28 and cultured them without cytokines or with IL-12 or IL-23 alone, or with either TGF-β plus IL-12 (with or without IL-1β and/or IL-6) or TGF-β plus IL-23 (with or without IL-1β and/or IL-6; thus, these conditions included the T H 17 condition of IL-23 plus TGF-β plus IL-6 plus IL-1β 24 ) and analyzed single-cell expression of Bcl-6, T-bet and RORγt by flow cytometry. Kinetics analysis showed that either TGF-β plus IL-12 or TGF-β plus IL-23 increased the expression of Bcl-6 and RORγt, which peaked 2-3 d after the addition of cytokines (thus, days 3-4 of culture; Fig. 5a and Supplementary Fig. 5a) . T-bet expression was lower after culture with TGF-β plus IL-12 or with TGF-β plus IL-23 than after culture with IL-12 alone or IL-23 alone, respectively ( Fig. 5a  and Supplementary Fig. 5a ). 
A r t i c l e s
We next assessed the expression of Bcl-6, T-bet, and RORγt by CXCR5 + helper T cells differentiated in various cytokine conditions. Whereas CXCR5 + helper T cells differentiated with IL-12 or IL-23 alone expressed little Bcl-6, more than 60% of CXCR5 + helper T cells differentiated with TGF-β plus IL-12 or with TGF-β plus IL-23 expressed Bcl-6 ( Fig. 5b and Supplementary Fig. 5b) . Among the CXCR5 + helper T cells differentiated with TGF-β plus IL-12 or with TGF-β plus IL-23, more than 70% of cells that expressed RORγt also expressed Bcl-6. The differentiation of CXCR5 + Bcl-6 + RORγt + helper T cells required IL-12 and IL-23, because TGF-β plus IL-6 induced CXCR5 + helper T cells expressing RORγt but not Bcl-6 ( Supplementary Fig. 5c ). Knockdown of RORγt mediated by small interfering RNA (siRNA) in helper T cells cultured in the T H 17 condition of IL-23, TGF-β, IL-6 and IL-1β enhanced the development of RORγt − Bcl-6 + cells (Supplementary Fig. 5d ), which confirmed that RORγt was not essential for the expression of Bcl-6. Furthermore, IL-17A + cells differentiated by culture of cord-blood naive helper T cells in the T H 17 condition noted above expressed both RORγt and Bcl-6 ( Fig. 5c) , and approximately 40% of helper T cells differentiated in this condition that expressed IL-17A also expressed IL-21 (Supplementary Fig. 5e ). Collectively, these results showed that either TGF-β plus IL-12 or TGF-β plus IL-23 induced CXCR5 + helper T cells that expressed both Bcl-6 and RORγt.
STAT3 and STAT4 act together with TGF-b in T FH differentiation
Whereas IL-12 and IL-23 activate both STAT4 and STAT3 in human helper T cells, STAT4 in IL-12 signaling and STAT3 in IL-23 signaling deliver the main activation signals 25 . We next determined whether STAT4 and STAT3 have distinct or redundant roles in expression of the transcriptional signatures of T FH cells and T H 17 cells by naive helper T cells cultured with TGF-β plus IL-12 or with TGF-β plus IL-23 (clusters III and IV, Fig. 4b) . We obtained naive helper T cells from the blood of human adults, transfected the cells with siRNA specifically designed to downregulate the expression of STAT4 or STAT3 (ref. 18 ) and cultured the cells with TGF-β plus IL-12 or with TGF-β plus IL-23. We also cultured the siRNA-transfected cells with combinations of TGF-β plus each of the following STAT3-activating cytokines: IL-6, IL-10 and IL-21. For this analysis, we normalized the abundance of each transcript analyzed in those cells separately to the abundance of that transcript in cells transfected with control Fig. 2a) ; results presented relative to those of cells cultured with no cytokines (as in Fig. 2c ). Each symbol represents an independent experiment; numbers at top indicate Pearson R values (P < 0.0001, except P = 0.0003 for IKZF4). (b) Unsupervised clustering of culture conditions according to the expression of transcription factors (above heat map) by adult naive helper T cells cultured for 3 d with various cytokines (left margin; as in Fig. 2a) ; results were normalized to those of cells cultured with no cytokines (presented as mean). Data are from eleven experiments. 
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cell-differentiation gene programs toward T FH cells and T H 17 cells and away from T reg cells and T H 2 cells.
A small fraction of tonsillar T FH cells express RORgt
Our observations suggested the existence of human T FH cells that expressed RORγt. However, published studies have concluded that human tonsillar CXCR5 hi ICOS hi GC T FH cells do not express RORγt, because expression of RORC mRNA is much lower in GC T FH cells than in T H 17 cells 27 . Analysis of mRNA transcripts showed that ex vivo human tonsillar CXCR5 hi ICOS hi GC T FH cells had modest expression of RORC mRNA, yet it was more abundant than that of CXCR5 − ICOS − naive helper T cells (Supplementary Fig. 6a) , which suggested that a subset of CXCR5 hi ICOS hi GC T FH cells might express RORγt. To address this, we analyzed the expression of Bcl-6 and RORγt in single human tonsillar T FH cells by flow cytometry and confocal microscopy. Flow cytometry showed that approximately 25% of CXCR5 hi ICOS hi Bcl-6 + GC T FH cells expressed RORγt (Fig. 7a) . As expected, back gating of Bcl-6 + cells showed that they were confined largely to the CXCR5 hi ICOS hi GC T FH subset among tonsillar helper T cells (Fig. 7b) . Analysis by confocal microscopy confirmed that Bcl-6 + helper T cells were largely limited to GCs (Supplementary Fig. 6b,c) .
Notably, back gating of Bcl-6 + RORγt + helper T cells revealed that these cells were also confined to the CXCR5 hi ICOS hi GC T FH cell subset (Fig. 7b) . In contrast, RORγt + cells lacking Bcl-6 expression were largely confined to the CXCR5 lo ICOS hi helper T cell subset (Fig. 7b) , a subset inefficient at providing help to B cells 7 . Furthermore, by confocal microscopy we found helper T cells expressing RORγt both outside the GCs and within the GCs (Fig. 7c,d) .
We also analyzed whether populations of human tonsillar GC T FH cells included subsets of cells expressing T-bet or GATA-3. GC T FH cells had more abundant expression of TBX21 mRNA than that of naive helper T cells (Supplementary Fig. 6a) . In contrast, expression of GATA3 mRNA was similar in GC T FH cells and naive helper T cells (Supplementary Fig. 6a ). Flow cytometry revealed that a small fraction of GC T FH cells that expressed Bcl-6 also expressed T-bet but not GATA-3 (Supplementary Fig. 6d) . Thus, populations of human tonsillar Bcl-6 + GC T FH cells included cells that expressed RORγt and T-bet but not GATA-3. Given that the microenvironment of inflamed tonsils is enriched for TGF-β and inflammatory cytokines, including IL-12 ( Fig. 3) , these observations support the observation that the combination of TGF-β and STAT3-and STAT4-activating cytokines induced the differentiation of naive helper T cells programs toward the T FH and T H 17 lineages but away from the T H 2 lineage.
TGF-b inhibits the differentiation of mouse T FH cells in vitro
The importance of TGF-β for the generation of T FH cells in vivo can potentially be tested in mouse models. However, a published study of mouse models has shown that blocking TGF-β does not decrease the expression of CXCR5 on activated helper T cells or the generation of GC B cells 28 . Furthermore, many studies of mouse helper T cells have shown that TGF-β inhibits the expression of Bcl-6 (refs. 14,28), partly Consistent with published studies 30 , although it promoted IL-17A expression, TGF-β inhibited IL-21 expression in a dose-dependent way in mouse helper T cells cultured under any cytokine combination tested ( Fig. 8 and Supplementary Fig. 7) . Furthermore, TGF-β also suppressed the expression of ICOS in a dose-dependent way. CXCR5 expression by helper T cells was minimal under all culture conditions (consistent with published studies 32 ), and TGF-β did not substantially affect CXCR5 expression. These results showed that the effect of TGF-β on the expression of T FH cell molecules differed in mice and humans and that positive regulation by TGF-β of the generation of T FH cells appeared to be limited to humans.
DISCUSSION
Published studies have suggested that IL-12 is important for the generation of T FH cells in humans 17, 18 . Subjects (particularly children) deficient in the β1 chain of the receptor for IL-12 (IL-12Rβ1) have diminished T FH cell and GC responses, which provides in vivo evidence that signaling via IL-12R is essential for the generation of T FH cells in humans 17 . However, stimulation with IL-12 by itself seems insufficient, because Bcl-6 expression in IL-12-stimulated human naive helper T cells is much lower than that in tonsillar T FH cells 17 . Furthermore, whereas IL-12Rβ1 is shared by the receptors for IL-12 and IL-23, whether IL-23 also contributes to the generation of human T FH cells has remained unknown. Our study here has demonstrated that both IL-12 and IL-23 contributed to the generation of human T FH cells and that TGF-β acted as a critical cofactor of IL-12 and IL-23
for the differentiation of T FH cells in humans. The transcriptional signature of T FH cells (that is, upregulation of the expression of Bcl-6, c-Maf and BATF and downregulation of the expression of Blimp-1) was induced when TGF-β was combined with IL-12 and IL-23. IL-23 promoted the expression of Blimp-1, but IL-12 did not. However, TGF-β diminished the ability of IL-23 to induce Blimp-1 expression. In inflammatory lymphoid organs, TGF-β had abundant expression in the T cell zone, where naive helper T cells interact with activated DCs. The presence of helper T cells with both phosphorylated Smad2 and phosphorylated STAT4 adjacent to GCs provided evidence that developing T FH cells receive signals that activate both pathways. We propose that an integration of these signals promotes human naive helper T cells to undergo gene programs to induce T FH differentiation, along with upregulation of the expression of multiple T FH cell molecules. Such an initial differentiation process probably promotes migration of the activated helper T cells toward follicles and their interactions with B cells to differentiate into mature T FH cells 9 .
Our study has shown that TGF-β and STAT3-and STAT4activating cytokines acted together in at least two aspects of the initial differentiation of human T FH cells. First, although it lacked this ability by itself, TGF-β enhanced the function of STAT3-STAT4 to induce human naive helper T cells to express T FH cell molecules, including CXCR5, ICOS, IL-21, Bcl-6, BATF-Jun and c-Maf. Notably, this stimulatory effect of TGF-β on the development of T FH cells seemed to be limited to human helper T cells and was not shared with mouse helper T cells. Enhanced Bcl-6 expression in human naive helper T cells cultured with TGF-β plus IL-12 or with TGF-β plus IL-23, together with IL-1β and IL-6, was mediated at least in part by increased BATF-Jun expression. Second, TGF-β suppressed and STAT3-STAT4 further downregulated (in the presence of TGF-β) Blimp-1 expression in human naive helper T cells. Because stimulation via the T cell antigen receptor is sufficient to induce human helper T cells to express Blimp-1, but not Bcl-6 (ref. 33 ), inhibition of Blimp-1 expression probably represents an important mechanism for shifting the Bcl-6-versus-Blimp-1 balance toward Bcl-6 dominance and thus to promote T FH differentiation. 
A r t i c l e s
We found that in contrast to TGF-β, type I and III interferons inhibited T FH differentiation by inhibiting the establishment of a T FH cell transcriptional signature, as well as the expression of T FH cell molecules. Type I interferon signals have been shown to inhibit the development of T FH cells in mice in vivo 34 , which suggests that this mechanism is shared by mice and humans. These observations would suggest that exaggerated T FH cell responses in human autoimmune diseases mediated by type I interferons, such as systemic lupus erythematosus 35 , is caused not by the direct effect of type I interferons on helper T cells but by an indirect effect on other cells of the immune system, such as DCs. This hypothesis is further supported by studies of mice demonstrating that the adjuvant effect of type I interferons on antibody response is mediated solely by interferon-responsive DCs 36, 37 .
The combination of TGF-β and STAT3-STAT4 induced in human naive helper T cells a differentiation program directed toward the T FH and T H 17 lineages and away from the T H 2 and T reg cell lineages. In this context, STAT3 and STAT4 contributed in a largely similar fashion and complemented each other. The combination of IL-23, TGF-β, IL-6 and IL-1β, the most common cytokine 'cocktail' for the generation of human T H 17 cells in vitro, was one of the most efficient cytokine combinations for the induction of Bcl-6 expression. RORγt-and IL-17A-expressing T H 17 cells generated with this cytokine 'cocktail' also expressed T FH cell molecules such as CXCR5, ICOS, IL-21 and Bcl-6, which indicated that developing T H 17 cells can share properties with T FH cells. This does not appear to be limited to developing cells, as human tonsillar GC T FH cells that expressed Bcl-6 included a subset that also expressed RORγt. In addition, memory T FH cells in the blood also include a subset that shares properties with T H 17 cells 38 . This memory T FH cell subset in the blood can be defined by the coexpression of CXCR5 and CCR6 and is more efficient at providing help to B cells than is the CCR6 − T FH cell subset in the blood 38, 39 . Notably, the frequency of CCR6 + blood T FH cell subset is higher in patients with various autoimmune diseases, including juvenile dermatomyositis 38 , Sjogren's syndrome 40 and multiple sclerosis 41 . These observations suggest that the T FH cell subset that shares properties with T H 17 cells represents a more efficient B cell-helper subset than other subsets, and an increase in these cells is associated with the development of human autoimmunity. Furthermore, both T FH cells and T H 17 cells emerge together in many human autoimmune diseases, including systemic lupus erythematosus 42 , rheumatoid arthritis 8 , Sjogren's syndrome 43 , multiple sclerosis 44 and juvenile dermatomyositis 38 . The shared developmental mechanism for T FH cells and T H 17 cells provides a strong mechanistic insight for their emergence together in these diseases. Given that TGF-β also has abundant expression in inflammatory sites in human autoimmune diseases 23, 45 in which tertiary lymphoid organs are often formed, it is presumable that TGF-β-rich inflammatory sites also contribute to the generation of T FH cells and T H 17 cells.
In conclusion, our study has demonstrated that TGF-β promoted T FH cell responses in an inflammatory environment by acting together with STAT3-and STAT4-activating cytokines. Our conclusions will provide insights into the pathogenesis of human autoimmune diseases. Establishing the global transcriptional network that promotes the human T FH cell-differentiation program and the expression of multiple T FH cell molecules, by a comprehensive approach, as used for mouse T H 17 cells 46 , might identify novel therapeutic target molecules for the treatment of human autoimmune diseases.
METHODS
Methods and any associated references are available in the online version of the paper.
